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Abstract 
BACKGROUND: Pugun tano extract had been studied for its effect as hepatoprotector. However, the usage of 
the plant in the form of extract has a limitation, especially if the extract is consumed by the people due to the 
unpleasant taste and odour. Then, the extract needs to be transformed into a particular dosage form, such as a 
capsule. But before the capsule can be produced, a preformulation study of pugun tano extract into a granule 
mass in capsule need to be evaluated. 
AIM: The study aimed to formulate the ethanolic extract of pugun tano (Curanga fel-terrae (Lour.) Merr) as 
granule mass in the capsule dosage form. 
METHODS: The pugun tano ethanolic extract was formulated in several steps included preparation of dry extract 
using coating method with polyvinylpyrrolidone (PVP) and granule mass production. The excipients used for the 
granule mass were lactose granules (made with tapioca starch using wet granulation), corn starch (made with 3 
concentrations of 5% (F1), 7.5% (F2) and 10% (F3)), talcum, magnesium stearate, methylparaben, and 
propylparaben. The granule mass was evaluated for the bulk density, tapped density, inter-particle porosity, Carr’s 
index, Hausner ratio, angle of repose, and flowability. 
RESULTS: The results showed that all of the formulae passed the requirement of the preformulation test. The 
bulk density of the granule mass was 0.79 – 0.86 g/ml; the tapped density was 0.88 – 0.90 g/ml; the inter-particle 
porosity was 0.03 – 0.14; the Carr’s index was 2.71 – 11.94%; the Hausner ratio was 1.09-1.12; the angle of 
repose was 26.10 – 28.90°; and the flowing time was 5.97 – 6.63 seconds. All of the formulae showed good 
flowability and free-flowing properties. 
CONCLUSION: It is concluded that the obtained formula containing pugun tano ethanolic extract can be 
formulated into granule mass for the capsule dosage form. 
 
 
 
 
Introduction 
 
The liver is a very important organ in the 
human body. The liver has to be protected due to its 
main role that metabolises all of the substance’s 
presence in the blood, including drugs. The drugs 
have the possibility to damage the liver if they have 
hepatotoxic properties, such as the usage of overdose 
paracetamol [1], [2]. Paracetamol or acetaminophen is 
the most widely used antipyretic and analgesic drug in 
the world, particularly in the United State [2]. The 
prevalence of the drug-induced liver failure was also 
detected approximately 20% in children and above 
20% in adults [3]. Therefore, we need to protect the 
liver from those kinds of substances. Since the drugs 
or supplements with hepatoprotective function are 
very limited, it is necessary to explore other 
alternatives to be used for that purpose.  
Curanga fel-terrae (Lour.) Merr is one of the 
plants which are abundant in East Asia-southern 
China, India through Myanmar, Malaysia to Indonesia 
and the Philippines. It has synonym of Picria fel-terrae 
(Lour) which belongs to Sapindaceae family [4]. The 
North Sumatera people usually called it as “pugun 
tano”. It contained some of the flavonoid compounds 
[5], which may act as the source of antioxidant that 
will maintain homeostasis and protect the liver [6]. The 
activity of this plant in the ethanol extract form as a 
hepatoprotective agent had been investigated by 
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Harahap et al., in 2017 [7]. The subchronic toxicity of 
the ethanolic extract had also been studied [8]. The 
usage of the plant in the form of extract has a 
limitation, especially if the extract is consumed by the 
people due to the unpleasant taste and odour. The 
right and practical dose are also other reasons 
whereby the extract needs to be formulated into a 
dosage form.  
The capsule is one of the solid dosage forms 
that is mostly used due to its simple preparation. The 
formulation and evaluation of the granule mass are 
the important aspects that need to be carried out to 
assure that the capsule exhibit a stable and effective 
dosage form. The characteristics of the granule mass 
are mostly affected by the particle properties. The 
flowability of the granule is the most important issue 
and it can affect the efficiency of the pharmacy 
production, particularly in hard gelatine capsule filling 
[9], [10]. Therefore, a preformulation study of granule 
mass for ethanolic extract of Curanga fel-terrae was 
conducted in a view to developing a pharmaceutical 
dosage form. 
 
 
Material and Methods 
 
Plant extraction 
The extraction of pugun tano was carried out, 
followed the method described in Harahap et al., [7]. 
The extraction was done using 96% of ethanol as the 
solvent. The result was stated as pugun tano 
ethanolic extract (PEE). 
 
Preparation of the granule mass 
The PEE was first coated with PVP as the 
coating agent; then this coated PEE was called dry 
pugun tano extract (DPE). The DPE was mixed with 
the other excipients to form the granules mass. The 
final mass of a capsule was determined by subtracting 
the total weight of a capsule with the capsule shell. 
The capacity for each capsule was 571 mg. The dose 
of DPE was chosen from the previous study by 
Harahap et al. as a hepatoprotective agent in rats [7] 
then the dose was converted to the dose of rabbit 
since the capsule will be evaluated for the 
hepatoprotective effect in the rabbit. The formula of 
the granule mass is shown in Table 1. 
Table 1. The formula of granule mass of pugun tano ethanolic 
extract 
Composition 
Weight (mg) 
F1 F2 F3 
DPE 406.25 406.25 406.25 
Corn starch 28.55 42.83 57.1 
Talc 5.71 5.71 5.71 
Mg stearate 5.71 5.71 5.71 
Methyl paraben 1.03 1.03 1.03 
Propyl paraben 0.11 0.11 0.11 
Lactose to 571 571 571 
 
Preformulation test of the granule mass 
The granules mixture was evaluated for its 
bulk density, tapped density, inter-particle porosity, 
Carr’s Index, Hausner ratio, angle of repose and 
flowability as described in previous studies [10], [11].  
 
Bulk and tapped density 
The bulk density was measured by recorded 
the volume (Vo) of known weight (M) of the granules 
mixture as well as after taping till constant volume (Vt) 
in a measuring cylinder. The bulk density (Ρb) and 
tapped density (Ρt) were calculated as M/Vo and M / 
Vt, respectively. 
 
Inter-particle porosity 
The inter-particle porosity of the granules 
mixture was calculated using the equation as 
described in Carbinato et al., [10].: Ie = {(Ρb – Ρt) / 
(Ρb x Ρt)}.   
 
Carr Index (CI%) 
This value was calculated from the bulk 
density and tapped density value as CI = ((Ρt – Ρb) / 
Ρt). 
 
Hausner ratio (HR) 
This ratio was calculated by dividing the 
tapped density to the bulk density as HR = Ρt / Ρb. 
 
The angle of repose (α) 
The angle of repose (α) was measured by 
determining the height (h) and the diameter (d) when 
a conical pie formed from flowing over a funnel and 
then calculated the tangent as follow: tan α = h / r. α 
was then deduced from its tangent. 
 
Flowability 
The flowability was determined by calculating 
the time consumed for the bulk to flow from a funnel. 
 
 
Results  
 
The result of coated PEE (DPE) and 
 granule mass 
The DPE acted as a base active ingredient in 
the capsule. The DPE was made in the form of a 
granule, therefore the additional excipients added 
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were in the form of fines and granules particle. The 
coated PEE (DPE) is shown in the Figure 1. 
 
Figure 1: The dry pugun tano extract (DPE) coated in 
polivynilpyrollidone as the base active ingredient 
 
The DPE was mixed with the other 
ingredients to form granule mass as the content of the 
capsules. Lactose was chosen as the filler and to 
increase the flow property of lactose; it was made in 
granules form. The modification of shape and size of 
powder will affect the flow properties more efficiently 
[12]. The granulation of lactose was also done to 
reduce the interparticle cohesive forces [13]. The 
difference made in the formula was the concentration 
of corn starch as the disintegrant. Assuming that the 
granule form from the DPE and lactose as the filler will 
make the pore and space increase, then the rest 
ingredients were in the fine powder form. The mixture 
of all of the ingredients can be seen in Figure 2.  
 
Figure 2: The mixture of all of the ingredients as the granules mass 
content of the capsule;, F1 = mixture contained 5% of corn starch; 
F2 = mixture contained 7.5% of corn starch, and F3 = mixture 
contained 10% of corn starch 
 
Preformulation Results 
The preformulation tests demonstrated the 
properties of the granules mass for each formula. The 
results of the preformulation tests are given in Table 
2. 
Table 2: The properties of granules mass for each formula (n = 
3), data are presented as mean ± SD 
Parameters F1 F2 F3 
Ρb (g/ml) 0.86 ± 0.06 0.79 ± 0.03 0.82 ± 0.02 
Ρt (g/ml) 0.90 ± 0.06 0.88 ± 0.03 0.89 ± 0.03 
Ie 0.03 ± 0.00 0.14 ± 0.00 0.10 ± 0.00 
Carr’s Index (%) 2.71 ± 0.00* 11.94 ± 0.00* 8.70 ± 0.00* 
Hausner ratio 1.04 ± 0.00 1.12 ± 0.00 1.09 ± 0.00 
Angle of repose α (
o
) 26.10 ± 0.02 28.90 ± 0.10 27.62 ± 0.08 
Flowing time (sec) 6.62 ± 0.07 5.97 ± 0.06 6.63 ± 0.09 
 
Discussion 
 
The bulk densities of all of the formula gave 
value above than 0.5 g/ml; it was shown that the 
granules mass had the denser characteristic. The high 
value of bulk density normally indicates great 
limitation to flow since the contact occurs among the 
particles. The tapped density value for each formula 
showed above than the bulk density value which 
indicated that there were empty spaces between the 
particles. The inter-particle porosity (Ie) result 
demonstrated the highest value obtained by F2 which 
was 0.14 ± 0.00 which supported that the biggest 
difference between bulk and tapped density in F2. It is 
indicated that there were plenty of pores and space 
between the particles in the F2 formula. The smallest 
Ie value was shown by F1 formula which had less 
space between the particles. The pores and empty 
spaces between the particles could influence the 
compressibility of the granules; therefore, it can affect 
the final volume of the capsule. The less Ie value 
would give compact granules mixture in a capsule 
which resulting in the weight of the granules mass had 
a small difference with the planned weight.  
The flowability of a granule mixture is 
influenced by the indirect flow-related properties such 
as Carr’s Index, Hausner ratio, and angle of repose. 
The Hausner ratio of all of the formula showed value 
in the range of 1.04 ± 0.00 to 1.12 ± 0.00 which 
indicated that the granule mixture had the good 
flowing characteristic. The Carr’s indexes were 2.71 ± 
0.00, 11.94 ± 0.00, 8.70 ± 0.00% for the formula F1, 
F2, F3, respectively. Based on Carr category on 
Carr’s index and Hausner ratio, F1 and F3 showed 
excellent flow properties and F2 showed good flow 
property [14]. Carr’s index below than 16% showed 
free-flowing property [15]. However, there was a 
significant difference between the F1, F2 and F3 
based on Carr’s index. The highest Carr’s index was 
resulted by F2 which mean that this formula was less 
free-flowing than other formula but still in the good 
flowing category [14]. The smallest Carr’s index was 
given by the formula F1 which was 2.71 ± 0.00%. The 
smallest Carr’s index indicating the higher 
compressibility, therefore, could gain more compact 
content of granule mass in the capsule [16]. 
The angle of repose of all of the formula gave 
value in the range of 26.10 ± 0.02° to 28.90 ± 0.10° 
which were between 25 – 30° indicating an excellent 
flow property [14]. These data were also supported by 
the result given by the flowing test. The flowing time 
for F1, F2 and F3 were 6.62 ± 0.07, 5.97 ± 0.06, and 
6.63 ± 0.09 seconds, respectively. All of the flow time 
demonstrated below than 10 seconds which mean 
that all of the formulae had excellent flow properties. 
However, there were no significant differences in the 
angle of repose and flowing time between each 
formula, indicating that all of the formula had the 
desirable flowing characteristic.  
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